EMD-27779

Single-particle
3.67 Å
EMD-27779 Deposition: 03/08/2022
Map released: 30/11/2022
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-27779

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8dya summary report (pdf.gz) Map-8dya FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of the SARS-CoV-2 spike glycoprotein S2 subunit

EMD-27779

Single-particle
3.67 Å
EMD-27779 Deposition: 03/08/2022
Map released: 30/11/2022
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 spike glycoprotein S2 subunit
Fitted models: 8dya

Deposition Authors: Park YJ , Seattle Structural Genomics Center for Infectious Disease (SSGCID), Veesler D
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines.
PUBMED: 36356052
DOI: doi:10.1126/sciimmunol.adf1421
ISSN: 2470-9468